Internal Medicine, Hematology & Oncology · Stuart, FL
NPI
1649591660
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
448 SE Osceola St
Stuart, FL, 34994
Phone (772) 276-7242
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.3M
257,622 services
Medicare patients, 2024
712
Average age 76
Drug cost, 2024
$6.5M
2,932 prescriptions
Company payments, 2025
$4,455
From 52 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christine G Simone was code J1439 (injection, ferric carboxymaltose, 1 mg), 54,750 times for 34 patients. In total Christine G Simone billed 257,622 services in 157 codes, and Medicare paid $4.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 54,750 | 34 | $0.87 | $48K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,800 | 20 | $41.95 | $914K |
| J0185 Injection, aprepitant, 1 mg | Office | 13,260 | 21 | $1.28 | $17K |
| J1627 Injection, granisetron, extended-release, 0.1 mg | Office | 10,600 | 23 | $4.31 | $46K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 5,400 | 35 | $0.10 | $564 |
| J0897 Injection, denosumab, 1 mg | Office | 5,160 | 39 | $20.16 | $104K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 5,016 | 11 | $20.59 | $103K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,176 | 47 | $0.09 | $369 |
| 85025 Blood Count | Office | 2,302 | 425 | $7.56 | $17K |
| 99214 Office E&M - Established | Office | 1,574 | 453 | $98.07 | $154K |
| 36415 Venipuncture Blood Collection | Office | 1,482 | 383 | $8.65 | $13K |
| 80053 Clinical Chemistry | Office | 1,322 | 359 | $10.34 | $14K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 640 | 13 | $0.65 | $419 |
| 96413 Chemotherapy Administration | Office | 574 | 82 | $102.82 | $59K |
| 96372 Injection Administration | Office | 482 | 57 | $11.40 | $5,497 |
By year: 2022 $2.2M for 133,296 services; 2023 $2.9M for 166,230 services; 2024 $4.3M for 257,622 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,302 | 425 | $7.56 | $17K |
| 36415 Venipuncture Blood Collection | 1,482 | 383 | $8.65 | $13K |
| 80053 Clinical Chemistry | 1,322 | 359 | $10.34 | $14K |
| 82728 Clinical Chemistry | 316 | 148 | $13.36 | $4,222 |
| 82607 Clinical Chemistry | 312 | 156 | $14.78 | $4,611 |
| 82746 Clinical Chemistry | 311 | 147 | $14.41 | $4,482 |
| 83735 Clinical Chemistry | 299 | 58 | $6.57 | $1,964 |
| 84443 Clinical Chemistry | 133 | 54 | $16.46 | $2,189 |
| 83540 Clinical Chemistry | 119 | 87 | $6.34 | $754 |
| 83550 Clinical Chemistry | 117 | 86 | $8.50 | $995 |
Medicare prescription drug claims, 2024
In 2024, the drug Christine G Simone prescribed most often to Medicare patients was Anastrozole, with 450 prescriptions and refills. In total Christine G Simone wrote 2,932 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 450 | 1,252 | 152 | $8,950 |
| Dexamethasone Generic | 250 | 251 | 64 | $1,437 |
| Prochlorperazine Maleate Generic | 113 | 113 | 86 | $4,657 |
| Ondansetron Hcl Generic | 109 | 109 | 79 | $2,741 |
| Letrozole Generic | 98 | 257 | 32 | $2,006 |
| Olanzapine Odt Olanzapine | 81 | 81 | 26 | $389 |
| Eliquis Apixaban | 79 | 121 | 20 | $69K |
| Olanzapine Generic | 78 | 78 | 17 | $240 |
| Udenyca Autoinjector Pegfilgrastim-Cbqv | 61 | 61 | 15 | $255K |
| Hydroxyurea Generic | 43 | 94 | 16 | $1,189 |
| Enoxaparin Sodium Generic | 39 | 47 | Under 11 | $14K |
| Prednisone Generic | 39 | 39 | Under 11 | $262 |
| Tamoxifen Citrate Generic | 38 | 102 | 13 | $1,522 |
| Tagrisso Osimertinib Mesylate | 38 | 38 | Under 11 | $646K |
| Paclitaxel Generic | 37 | 37 | 11 | $4,954 |
Brand drugs: 817 claims; generic drugs: 2,115 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christine G Simone $4,455 ($4,455 in general payments such as food, travel and fees) from 52 companies. The largest payer was Janssen Biotech, Inc. with $517.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 23 | $517 |
| Pfizer Inc. PFE | 23 | $321 |
| Daiichi Sankyo Inc. 4568.T | 12 | $309 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $289 |
| GlaxoSmithKline, LLC. GSK | 9 | $279 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $250 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $177 |
| Incyte Corporation INCY | 6 | $152 |
| Celgene Corporation BMY | 7 | $136 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.